Archive for August, 2023

Semaglutide side effects can include both common and serious adverse reactions. Common side effects of semaglutide encompass nausea, vomiting, diarrhea, abdominal pain, constipation, and headaches. Strategies to manage these effects include a slow titration of the dosage, maintaining adequate hydration, and using medication to control symptoms as necessary. On the other hand, serious adverse effects […]

Victoza (liraglutide) is a GLP-1 receptor agonist medication commonly prescribed for type 2 diabetes and medical weight loss. Like many medications that affect appetite, digestion, and blood sugar regulation, Victoza may cause both mild and serious side effects depending on the individual, dosage, and overall health history. Many side effects are temporary and improve as […]

Trulicity (dulaglutide) is a GLP-1 receptor agonist medication commonly prescribed for Type 2 diabetes and, in some cases, medical weight management. Like other medications in this class, Trulicity affects appetite, digestion, and blood sugar regulation, which means some patients may experience mild or more serious side effects during treatment. Understanding how Trulicity works, what side […]

Ozempic has become one of the most widely discussed medications for type 2 diabetes. Ozempic is not FDA-approved for weight management; use for weight loss is off-label. Wegovy and Zepbound are labeled for weight management. The medication belongs to a class of drugs called GLP-1 receptor agonists, which help regulate blood sugar levels, slow digestion, […]

When it comes to the safety of medications, weighing the potential side effects of the treatment against the risk of not treating the condition is crucial. Mounjaro is not FDA-approved for weight management; use for weight loss is off-label. Zepbound contains the same drug and is labeled for weight management. It’s important to be aware […]